Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
[Efficacy and safety of natalizumab in multiple sclerosis: data from the first five years of TOP (Tysabri Observational Program) study].
Changes of Synaptic Plasticity in Multiple Sclerosis.
No evidence of human herpesvirus DNA in the CSF of multiple sclerosis patients.
Intestinal Interleukin-17 Receptor Signaling Mediates Reciprocal Control of the Gut Microbiota and Autoimmune Inflammation.
Mosaic Subventricular Origins of Forebrain Oligodendrogenesis.
Toxicity of cuprizone a Cu(2+) chelating agent on isolated mouse brain mitochondria: a justification for demyelination and subsequent behavioral dysfunction.
The Effect of Disease-Modifying Drugs on Brain Atrophy in Relapsing-Remitting Multiple Sclerosis: A Meta-Analysis.
Heterogeneity of Multiple Sclerosis Lesions in Multislice Myelin Water Imaging.
Allelic imbalance of multiple sclerosis susceptibility genes IKZF3 and IQGAP1 in human peripheral blood.
Autoimmune disease in people with multiple sclerosis and their relatives: a systematic review and meta-analysis.
Myoinositol trends in different types of brain lesions.
Adaptive Immune Responses in a Multiple Sclerosis Patient with Acute Varicella-Zoster Virus Reactivation during Treatment with Fingolimod.
Grey matter involvement by focal cervical spinal cord lesions is associated with progressive multiple sclerosis.
Bromodomains: translating the words of lysine acetylation into myelin injury and repair.
Long-distance effects of inflammation on differentiation of adult spinal cord neural stem/progenitor cells.
Detection of demyelination in multiple sclerosis by analysis of [Formula: see text] relaxation at 7 T.
Relating multi-sequence longitudinal intensity profiles and clinical covariates in incident multiple sclerosis lesions.
Upper Limb Rehabilitation in People With Multiple Sclerosis: A Systematic Review.
Sulfatide-mediated control of extracellular matrix-dependent oligodendrocyte maturation.
Cognitive-Motor Interference in Multiple Sclerosis: A Systematic Review of Evidence, Correlates, and Consequences.
Cardiovascular effects of fingolimod: Relevance, detection and approach.
The roles of extracellular related-kinases 1 and 2 signaling in CNS myelination.
Transcript analysis of laser capture microdissected white matter astrocytes and higher phenol sulfotransferase 1A1 expression during autoimmune neuroinflammation.
The antineoplastic properties of FTY720: Evidence for the repurposing of fingolimod.
Responsiveness of selected outcome measures of participation restriction and quality of life in patients with multiple sclerosis.
Pages
« first
‹ previous
…
660
661
662
663
664
665
666
667
668
…
next ›
last »